BUDGET IMPACT ANALYSIS OF VIACORAM FOR THE TREATMENT OF HYPERTENSION IN ITALY

被引：0
|
作者：
Lanati, E. P. [1 ]
Orlando, V. L. [1 ]
Doratori, S. [2 ]
机构：
[1] MA Provider Srl, Milan, Italy
[2] Servier Italia, Rome, Italy
来源：
VALUE IN HEALTH | 2016年 / 19卷 / 07期
关键词：
D O I：
10.1016/j.jval.2016.09.1712
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCV44
引用
收藏
页码：A644 / A644
页数：1
相关论文
共 50 条
  • [1] BUDGET IMPACT ANALYSIS OF TRIVERAM FOR THE TREATMENT OF HYPERTENSION IN ITALY
    Lanati, E. P.
    Orlando, V. L.
    Doratori, S.
    VALUE IN HEALTH, 2016, 19 (07) : A643 - A643
  • [2] BUDGET IMPACT ANALYSIS OF TRIPLIAM FOR THE TREATMENT OF HYPERTENSION IN ITALY
    Lanati, E. P.
    Orlando, V. L.
    VALUE IN HEALTH, 2015, 18 (07) : A384 - A384
  • [3] BUDGET IMPACT ANALYSIS OF ENSTILAR FOR THE TREATMENT OF PSORIASIS IN ITALY
    Lanati, E. P.
    Orlando, V. L.
    VALUE IN HEALTH, 2017, 20 (09) : A802 - A802
  • [4] RADIOFREQUENCY-BASED RENAL DENERVATION FOR TREATMENT-RESISTANT HYPERTENSION IN ITALY: A BUDGET IMPACT ANALYSIS
    Maglionico, G.
    Autiero, Walleser S.
    Borghetti, F.
    Taddei, S.
    VALUE IN HEALTH, 2022, 25 (01) : S48 - S48
  • [5] Venous tromboembolism treatment: budget impact analysis of rivaroxaban in Italy
    Roggeri, Daniela Paola
    Roggeri, Alessandro
    Pengo, Vittorio
    FARMECONOMIA-HEALTH ECONOMICS AND THERAPEUTIC PATHWAYS, 2014, 15 (04) : 113 - 127
  • [6] Budget impact analysis of empagliflozin for the treatment of type 2 diabetes in Italy
    Iannazzo, Sergio
    Mannucci, Edoardo
    Mantovani, Lorenzo
    FARMECONOMIA-HEALTH ECONOMICS AND THERAPEUTIC PATHWAYS, 2016, 17 (01) : 19 - 27
  • [7] Budget impact analysis of the use of rituximab in the treatment of rheumatoid arthritis in Italy
    Benucci, Maurizio
    Iannazzo, Sergio
    Sabadini, Luciano
    FARMECONOMIA-HEALTH ECONOMICS AND THERAPEUTIC PATHWAYS, 2009, 10 (01) : 19 - 31
  • [8] Budget impact analysis of the use of lapatinib in the treatment of breast cancer in Italy
    Bamfi, Francesco
    Basso, Federica
    Aglietta, Massimo
    Bengala, Carmelo
    Lorusso, Vito
    Pronzato, Paolo
    Cavallo, Maria Caterina
    Zaniolo, Orietta
    Iannazzo, Sergio
    FARMECONOMIA-HEALTH ECONOMICS AND THERAPEUTIC PATHWAYS, 2009, 10 (01) : 33 - 46
  • [9] Rituximab in the treatment of rheumatoid arthritis patients in Italy: a budget impact analysis
    Benucci, M.
    Iannazzo, S.
    Zaniolo, O.
    Sabadini, L.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2010, 28 (05) : 722 - 727
  • [10] A BUDGET IMPACT ANALYSIS TO ESTIMATE THE ECONOMIC IMPACT OF SEVIKARHCT® FOR THE TREATMENT OF ARTERIAL HYPERTENSION IN SPAIN
    Darba, J.
    Kaskens, L.
    Nilsson, J.
    Oberdiek, A.
    VALUE IN HEALTH, 2011, 14 (07) : A371 - A372
12345